{"name":"Matrix Biomed, Inc.","slug":"matrix-biomed-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MBM-02","genericName":"MBM-02","slug":"mbm-02","indication":"Metastatic non-small cell lung cancer","status":"phase_2"}]}],"pipeline":[{"name":"MBM-02","genericName":"MBM-02","slug":"mbm-02","phase":"phase_2","mechanism":"MBM-02 is a small molecule that targets the PI3K/AKT pathway.","indications":["Metastatic non-small cell lung cancer","Metastatic breast cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNeVpvY1B1ZUJVck9CdDJNOG5VcFExUW5NeGlwR3NZdmxlZTE1eWNILWtGSk9tU0pqSnpZR0V3dW5wQmJOYy1hZHBRR2FIWTVKb2Vjcm8wUjZKN1Q1M21fUGs2VFZ5bDBmX2dTN1pvcjczczZPZWJYQ1M4YXRXRkNMS29pNFlSUEhrVkZvY3Y1bmY3QmN2Z3c?oc=5","date":"2026-03-05","type":"pipeline","source":"CommercialSearch","summary":"BioMed Realty Lands Full-Building Tenant Near Denver - CommercialSearch","headline":"BioMed Realty Lands Full-Building Tenant Near Denver","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOazJuak55VGh1NzN1UGw1c1F6YWVMU19YQklldmFvNklSRHRTYWJRM1Y2RzlvaUZtWmp4Nm9HSWlrNWZWQkIxVkFXQjY1RjRBNks4S1pDczl6a0E4M1pXTkF1RmhSdjVON1d5Q1lMRWxyVUtYMlF0NnhVbHpuS2IxaUpvQUdNWFlZc2lpcDJ1TkZVLXpmakhBNHpvSmV3Q19US0hOTnF1bUxCVkhzUlNpTVVDRnpQdHN4X2JhVkkxSHBRZ2x0SzcxMU1ON3ktWURqcm5tVnRNS1o?oc=5","date":"2024-05-30","type":"pipeline","source":"PR Newswire","summary":"Stuttering Market to Register Stunning Growth at a CAGR of 13.4% by 2034 | DelveInsight - PR Newswire","headline":"Stuttering Market to Register Stunning Growth at a CAGR of 13.4% by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1Va1hkRGsxZk9reEJ2RVpsc0Y5bHJZbWZzZkNMNWpZeGl4c1FFQWRZd2N5aTN4ai1XZWJ4cE01TjZ6Vl9pTlE5dV9lLXNvUUlEclFpSUo1NXlFSlc0MFdVMHN1a3UyelJHTmVSa2VR?oc=5","date":"2022-11-10","type":"pipeline","source":"Spherical Insights","summary":"Global Ataxia Market Size, Growth, Price, Trends reports to 2030 - Spherical Insights","headline":"Global Ataxia Market Size, Growth, Price, Trends reports to 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQUXZhcWFuNDNhV0I1SmZmSXUzRFhLakp6emJRYUtOZWNtaEdBVlAxUUduV2g5emVMTUUtLTJDOFBiMXJTUTZOSjNzYlVSNGppcjJLZUpwY0F5SS1YaWVRc3RnUS00UXV4TFRtbGVLcXNic3RHbC1INUV2emw3QnR4dUZTSkFpZkxkdlFMQ09B?oc=5","date":"2022-06-13","type":"trial","source":"globaldata.com","summary":"Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - globaldata.com","headline":"Oral Mucositis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxOQ1QyMjdLTTc1MTJZT1hsUGZ3OWRXU3RSZWlLVUsxSlVaYUozTGZkMlU5ZGRFUDhSSDJWS0JVRE9IWUpIc2FmbWd4bmZFZEJqb05jNUlubmdFSEVNVl9aczRkNzU3bnR3QXlVT0lpQjk2YkVsbFFmSlVBaFhtaTZDSkZ0VU5jOWtCUl9CSjZmek5ZNFRXSllCc1NlSjhHeVp6a2l2dDAyZkhZWXU0RGdNd1JLREcxWVZYSVJQY0NWODM4Ymk3U3g1WTFfLTc2SlZxVXZsYk5GcWgzTWtsRGlzRw?oc=5","date":"2018-03-02","type":"pipeline","source":"Biotech Newswire","summary":"Judith Heikoop Appointed Managing Director at Biomedical Electro Spinning Company IME Technologies - Biotech Newswire","headline":"Judith Heikoop Appointed Managing Director at Biomedical Electro Spinning Company IME Technologies","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}